Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Aug;272(5):753-755.
doi: 10.1007/s00406-022-01445-1.

Mental health during the COVID-19 pandemic, impact of childhood trauma in psychiatric disorders, and predictable biomarkers for bipolar disorder

Kenji Hashimoto  1
Affiliations
Editorial

Mental health during the COVID-19 pandemic, impact of childhood trauma in psychiatric disorders, and predictable biomarkers for bipolar disorder

Kenji Hashimoto. Eur Arch Psychiatry Clin Neurosci. 2022 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Dr. Hashimoto is the inventor of filed patent applications on “The use of R-ketamine in the treatment of psychiatric diseases”, “(S)-norketamine and salt thereof as pharmaceutical”, “R-ketamine and derivative thereof as prophylactic or therapeutic agent for neurodegeneration disease or recognition function disorder”, “Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases”, “R-ketamine and its derivatives as a preventive or therapeutic agent for a neurodevelopmental disorder”, and “TGF-β1 in the treatment of depression” by the Chiba University. Dr. Hashimoto has also received speakers’ honoraria, consultant fee, or research support from Abbott, Daiichi-Sankyo, Meiji Seika Pharma, Seikagaku Corporation, Sumitomo, Taisho, Otsuka, Murakami Farm, and Perception Neuroscience.

Comment on

References

    1. Bartels C, Hessmann P, Schmidt U, Vogelgsang J, Ruhleder M, Kratzenberg A, Treptow M, Reh-Bergen T, Abdel-Hamid M, Heß L, Meiser M, Signerski-Krieger J, Radenbach K, Trost S, Schott BH, Wiltfang J, Wolff-Menzler C, Belz M. Medium-term and peri-lockdown course of psychosocial burden during the ongoing COVID-19 pandemic: a longitudinal study on patients with pre-existing mental disorders. Eur Arch Psychiatry Clin Neurosci. 2022;25:1–15. doi: 10.1007/s00406-021-01351-y. - DOI - PMC - PubMed
    1. Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, Lekoubou A, Oh JS, Ericson JE, Ssentongo P, Chinchilli VM. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568. - DOI - PMC - PubMed
    1. Poletti S, Palladini M, Mazza MG, De Lorenzo R, COVID-19 BioB Outpatient Clinic Study group. Furlan R, Ciceri F, Rovere-Querini P, Benedetti F. Long-term consequences of COVID-19 on cognitive functioning up to 6 months after discharge: role of depression and impact on quality of life. Eur Arch Psychiatry Clin Neurosci. 2022;26:1–10. doi: 10.1007/s00406-021-01346-9. - DOI - PMC - PubMed
    1. Lin J, Su Y, Lv X, Liu Q, Wang G, Wei J, Zhu G, Chen Q, Tian H, Zhang K, Wang X, Zhang N, Yan H, Wang Y, Yu X, Si T. Childhood adversity, adulthood adversity and suicidal ideation in Chinese patients with major depressive disorder: in line with stress sensitization. Eur Arch Psychiatry Clin Neurosci. 2022 doi: 10.1007/s00406-021-01375-4. - DOI - PubMed
    1. Kratzer L, Knefel M, Haselgruber A, Heinz P, Schennach R, Karatzias T. Co-occurrence of severe PTSD, somatic symptoms and dissociation in a large sample of childhood trauma inpatients: a network analysis. Eur Arch Psychiatry Clin Neurosci. 2022 doi: 10.1007/s00406-021-01342-z. - DOI - PMC - PubMed